BlackRock Inc. Sells 20,013 Shares of DENTSPLY SIRONA Inc (XRAY)

BlackRock Inc. lowered its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,077,089 shares of the medical instruments supplier’s stock after selling 20,013 shares during the period. BlackRock Inc. owned about 6.33% of DENTSPLY SIRONA worth $531,270,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Piedmont Investment Advisors LLC acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at $117,000. Qube Research & Technologies Ltd acquired a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at $134,000. NuWave Investment Management LLC boosted its stake in shares of DENTSPLY SIRONA by 22,360.0% in the 3rd quarter. NuWave Investment Management LLC now owns 3,369 shares of the medical instruments supplier’s stock valued at $127,000 after purchasing an additional 3,354 shares in the last quarter. Rockefeller Capital Management L.P. boosted its stake in shares of DENTSPLY SIRONA by 1,941.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 3,369 shares of the medical instruments supplier’s stock valued at $127,000 after purchasing an additional 3,204 shares in the last quarter. Finally, Exane Asset Management boosted its stake in shares of DENTSPLY SIRONA by 41.3% in the 2nd quarter. Exane Asset Management now owns 4,678 shares of the medical instruments supplier’s stock valued at $205,000 after purchasing an additional 1,368 shares in the last quarter. Hedge funds and other institutional investors own 96.21% of the company’s stock.

XRAY has been the topic of several recent analyst reports. ValuEngine upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research note on Monday, August 13th. TheStreet downgraded shares of DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research report on Tuesday, August 14th. HC Wainwright set a $40.00 price target on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, August 31st. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Thursday, September 27th. Finally, Goldman Sachs Group upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 price target on the stock in a research report on Friday, October 19th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $51.50.

In related news, insider Markus Boehringer sold 7,373 shares of the company’s stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $37.86, for a total transaction of $279,141.78. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.93% of the stock is owned by corporate insiders.

Shares of NASDAQ XRAY opened at $36.31 on Friday. The stock has a market cap of $8.19 billion, a P/E ratio of 13.65, a P/E/G ratio of 2.24 and a beta of 1.18. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.14 and a current ratio of 1.76. DENTSPLY SIRONA Inc has a 12-month low of $33.93 and a 12-month high of $68.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.08). The company had revenue of $928.40 million for the quarter, compared to analyst estimates of $951.58 million. DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. The firm’s quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the company earned $0.70 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA Inc will post 1.97 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/12/08/blackrock-inc-sells-20013-shares-of-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: The Discount Rate – What You Need to Know

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply